Patent directory · USPTO A61K / A61P
Patents matching “cells”
914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10544392
Methods of isolating T cells and T cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood
granted -
US 10526576
Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells
granted -
US 10519247
Targeting HER2 and HER3 with bispecific antibodies in cancerous cells
granted -
US 10512691
Systems and methods for targeted imaging and ablation of cardiac cells
granted -
US 10500277
Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma
granted -
US 10485879
Plasma cell cytokine vehicle containing fusion proteins for targeted introduction of siRNA into cells and tissues
granted -
US 10485829
Methods of producing human RPE cells and pharmaceutical preparations of human RPE cells
granted -
US 10479839
Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
granted -
US 10480031
Method for generating Retinal Pigment Epithelium (RPE) cells from Induced Pluripotent Stem Cells (IPSCs)
granted -
US 10464989
Polypeptides, cells, and methods involving engineered CD16
granted -
US 10441546
Bacterially derived intact minicells that encompass plasmid free DNA and methods of using the same
granted -
US 10434174
Combination therapies using platinum agents and agents that target tumor-associated stroma or tumor cells
granted -
US 10428133
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
granted -
US 10426736
Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
granted -
US 10426799
Methods for production of platelets from pluripotent stem cells and compositions thereof
granted -
US 10428113
Compositions for expanding regulatory T cells (Treg), and treating autoimmune and inflammatory diseases and conditions
granted -
US 10428143
Modulation of stimulatory and non-stimulatory myeloid cells
granted -
US 10415015
Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion
granted -
US 10406248
Molecular imaging of cancer cells in vivo
granted -
US 10406125
Combination comprising an aminothiolester compound or a pharmaceutically acceptable salt thereof and a compound able to increase the H2O2 level in cancer cells of a subject
granted -
US 10406177
Modified cells and methods of therapy
granted -
US 10400045
Internalizing human monoclonal antibodies targeting prostate and other cancer cells
granted -
US 10391126
CAR+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA
granted -
US 10383827
Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
granted